Clinical Trial Update: Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study [Phase 2]

View source ↗

Summary

Phase 2 randomized neoadjuvant study evaluating a PD-1 monoclonal antibody in combination with interleukin-2 and CapeOX for locally advanced Rectal Cancer prior…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Interleukin-2 (interleukin-2)
• OXALIPLATIN (Oxaliplatin)
• PD-1 monoclonal antibody

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Rectal Cancer | Phase 2 | Status: RECRUITING